FDA Inspection 1167650 — The Center For Human Reproduction D.B.A. American Infertility Of New York, P.C.

The Center For Human Reproduction D.B.A. American Infertility Of New York, P.C. — FEI 3003969128

The FDA completed an inspection of The Center For Human Reproduction D.B.A. American Infertility Of New York, P.C. on Apr 11, 2022 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Apr 11, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New York, NY (United States)